The Use of Pecs Blocks in Combination With Exparel in Breast Reconstruction Surgery

Launched by NORTHWESTERN UNIVERSITY · Dec 14, 2021

Keywords

ClinConnect Summary

This clinical trial is studying a new way to manage pain during breast reconstruction surgery. Specifically, it is looking at how a special type of nerve block, called a Pecs block, can be used along with a pain relief medication called Exparel. The goal is to see if this combination can help reduce pain after surgery, lower the need for stronger painkillers (like opioids), and improve how quickly patients can get back to their normal activities.

To participate in this trial, women aged 18 and older who are having implant-based breast reconstruction surgery may be eligible. However, those undergoing other types of surgeries, such as flap reconstruction or direct-to-implant surgery, or those who have had radiation therapy before, will not be included. Participants can expect to receive the Pecs block and Exparel during their procedure, and the study will monitor their recovery, focusing on pain levels and overall activity after surgery. This research aims to improve the experience for women undergoing breast reconstruction.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. Subjects greater than 18 years of age.
• • 2. Subject who are undergoing implant-based, tissue expander breast reconstruction surgery.
• Exclusion Criteria:
• • 1. Subjects undergoing flap breast reconstruction.
• • 2. Subjects who are undergoing direct-to-implant surgery.
• • 3. Subjects who have previously undergone radiation therapy.
• • 4. Medical or psychiatric condition that may increase the risk associated with study participation, may complicate patient compliance, or may interfere with the interpretation of study results and, in the judgment of the Investigator, would make the subject inappropriate for entry into this study.
• • 5. Subjects who are pregnant at the date of surgery.